期刊文献+

系统性炎症指标在哮喘-慢阻肺重叠鉴别诊断中的运用价值

Application value of systemic inflammatory index in thedifferential diagnosis of asthma-COPD overlap
下载PDF
导出
摘要 目的分析系统性炎症指标在哮喘-慢阻肺重叠中的诊断价值。方法选取2021年1月-2022年12月本院收治的247例慢性呼吸道疾病患者,根据临床诊断分为ACO组(88例),Asthma组(75例),COPD组(84例),比较3组患者基线资料及系统性炎症指标的差异。通过受试者工作特征曲线评价各指标对ACO的鉴别效能。结果3组患者NLR、PLR、LMR、SII及SIRI间的差异均有统计学意义(P<0.05)。NLR>3.420、PLR>162.17、SII>772.26、SIRI>1.475、LMR<2.645五个指标联合诊断Asthma与ACO的ROC曲线下面积为0.758(95%CI:0.682~0.833,P<0.05),具有较好的诊断效能。结论COPD、Asthma与ACO 3组患者的NLR、PLR、LMR、SII、SIRI等系统性炎症指标分布有差异,且与其肺功能指标存在一定的相关性。联合运用5个指标对于Asthma与ACO的鉴别有一定的诊断价值。 Objective To analyze the diagnostic value of systemic inflammatory index in asthma-COPD overlap.Methods A total of 247 patients with chronic respiratory diseases were admitted to our hospital from January 2021 to December 2022,they were divided into ACO group(88 cases),Asthma group(75 cases)and COPD group(84 cases)according to clinical diagnosis.The differences of baseline data and systemic inflammation indexes among the three groups were compared.The identification efficiency of each index to ACO was evaluated by subject operating characteristic curve.Results The differences of NLR,PLR,LMR,SII and SIRI among the three groups were statistically significant(P<0.05).The area under ROC curve of five indexes with NLR>3.420,PLR>162.17,SII>772.26,SIRI>1.475,LMR<2.645,EBR<1.38 for combined diagnosis Asthma and ACO was 0.758(95%CI:0.682~0.833,P<0.05),which had good diagnostic efficacy.Conclusions There are differences in the distribution of systemic inflammatory indicators such as NLR,PLR,LMR,SII and SIRI in COPD,Asthma and ACO groups,and there is a certain correlation with their pulmonary function indicators.The combined application of 5 indexes has certain diagnostic value for the identification of Asthma and ACO.
作者 李颖 李胡焕 李春梅 杨宇溪 徐文波 尹皓原 LI Ying;LI Huhuan;LI Chunmei;YANG Yuxi;XU Wenbo;YIN Haoyuan(Department of Clinical Laboratory;Department Thoracic Surgery,Yuxi People's Hospital/Sixth Affiliated Hospital of Kunming Medical University,Yuxi Yunnan 653100,China)
出处 《云南医药》 CAS 2024年第4期24-27,共4页 Medicine and Pharmacy of Yunnan
基金 国家自然科学基金(82160402) 云南省教育厅科学研究基金项目(2022J0203)。
关键词 系统性炎症指标 哮喘-慢阻肺重叠 鉴别诊断 systemic inflammatory markers asthma-COPD overlap differential diagnosis
  • 相关文献

参考文献5

二级参考文献86

共引文献3048

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部